跳至主要内容
临床试验/NL-OMON47060
NL-OMON47060招募中不适用

Replacement of invasive diagnostic coronary procedures by innovative noninvasive Imaging Technologies - REPLACE-IT

niversitair Medisch Centrum Groningen0 个研究点目标入组 440 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
440

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • - Planned for a ICA as part of standard clinical care for evaluation of suspected CAD
  • - Age >=18 years

排除标准

  • - Unable to provide written informed consent
  • - ICA planned for other reasons than suspected obstructive CAD (e.g. screening prior to lung transplantation, valvular surgery, or ICD implantation)
  • - Significant arrhythmia deemed to interfer with successful ECG triggered non-invasive imaging as judged by a cardiologist.
  • - Renal insufficiency: GFR <50ml/min
  • - Known anaphylactic allergy to iodine
  • - Known severe comorbidities with a life expectancy of less than 1 year
  • - Known severe claustrophobia
  • - Known contra-indications for beta-blocker or adenosine
  • - Instable coronary artery disease (acute coronary syndrome or instable angina)
  • - Other contraindications for CTA or MR perfusion (e.g. presence of incompatible pacemaker or ICD devices/leads, pregnancy, BMI >35 kg/m2).

研究者

相似试验